Evolving Compliance: Adapting to AI and Digital Systems in Clinical Research
The regulatory landscape for clinical development and pharmaceutical manufacturing is shifting as the European Commission proposes updates to Good Manufacturing Practice (GMP) guidelines, particularly regarding digital systems and artificial intelligence (AI). These changes aim to enhance compliance and oversight, ensuring that digital records and AI tools meet the evolving standards in clinical trials and drug development.